Early research (Phase 1)Study completedNCT03846843What this trial is testingOCR002-SP103 - Oral Immediate Release StudyWho this might be right forCirrhosis Ocera Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT05088642What this trial is testingA Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsWho this might be right forSever Aplastic Anaemia Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT01405573What this trial is testingSorafenib in First-line Treatment of Advanced B Child Hepatocellular CarcinomaWho this might be right forAdvanced Adult Hepatocellular Carcinoma National Cancer Institute, Naples 35
Large-scale testing (Phase 3)UnknownNCT00921531What this trial is testingAdjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Fudan University 200
Early research (Phase 1)Study completedNCT02507765What this trial is testingStereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forChild-Pugh Class AChild-Pugh Class BStage IIIA Hepatocellular Carcinoma+4 more Ohio State University Comprehensive Cancer Center 16
Early research (Phase 1)Not Yet RecruitingNCT06994572What this trial is testingStudy of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Captor Therapeutics S.A. 141
Early research (Phase 1)Study completedNCT06888115What this trial is testingThe Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic InjuryWho this might be right forPrimary Biliary Cholangitis Cascade Pharmaceuticals, Inc 24
Post-approval studies (Phase 4)Study completedNCT01846455What this trial is testingSingle Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired SubjectsWho this might be right forHepatic FailureHepatic ImpairmentChronic Hepatitis C Infection With Hepatic Coma Indivior Inc. 43
Testing effectiveness (Phase 2)Study completedNCT02128958What this trial is testingPhase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma Can-Fite BioPharma 78
Early research (Phase 1)Ended earlyNCT04136444What this trial is testingA Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic FunctionWho this might be right forHealthy Study ParticipantsImpaired Hepatic Function UCB Biopharma S.P.R.L. 12
Large-scale testing (Phase 3)Ended earlyNCT02762266What this trial is testingTransarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial ChemoembolizationWho this might be right forChild-Pugh Class AChild-Pugh Class BRecurrent Hepatocellular Carcinoma Stanford University 13
Early research (Phase 1)Looking for participantsNCT06957756What this trial is testingTest How BI 1584862 is Taken up in the Blood of People With and Without Liver ProblemsWho this might be right forHepatic Insufficiency Boehringer Ingelheim 44
Large-scale testing (Phase 3)Study completedNCT02201901What this trial is testingSofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B CirrhosisWho this might be right forHepatitis C Virus Infection Gilead Sciences 268
Testing effectiveness (Phase 2)Ended earlyNCT04497038What this trial is testingCabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line TherapyWho this might be right forAdvanced Adult Hepatocellular Carcinoma University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01188733What this trial is testingEfficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With CirrhosisWho this might be right forCirrhosisPortal HypertensionEsophageal Varices Mayo Clinic 39